Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Syngene International Ltd. ( (IN:SYNGENE) ) has issued an update.
Syngene International Limited reported an 11% increase in fourth-quarter revenue, reaching Rs. 1,018 crore, marking the first time quarterly revenue exceeded Rs. 1,000 crore. The full-year revenue saw a 4% rise to Rs. 3,642 crore, although profit after tax before exceptional items decreased by 8% to Rs. 475 crore. Despite the decline in annual profit, the company’s operational growth and revenue milestones reflect its robust performance and strategic market positioning.
More about Syngene International Ltd.
Syngene International Limited operates in the biotechnology industry, providing integrated research, development, and manufacturing services. The company focuses on delivering solutions to pharmaceutical, biotechnology, and agrochemical sectors, enhancing its market presence through innovation and strategic partnerships.
YTD Price Performance: -16.27%
Average Trading Volume: 46,039
Current Market Cap: 296B INR
For detailed information about SYNGENE stock, go to TipRanks’ Stock Analysis page.